Royal Philips has marked a transformative moment in medical imaging with the launch of Verida, announced at the RSNA 2025 conference in Chicago. This system is heralded as the world's first detector-based spectral CT scanner fully powered by artificial intelligence.
A New Era in Diagnostic Imaging
The introduction of Verida represents a significant technological leap. By integrating AI across the entire imaging chain—from acquisition to reconstruction—the system achieves what was previously challenging: lowering system noise while simultaneously elevating image quality and accelerating clinical workflow. This holistic AI approach optimizes every step of the imaging process.
Philips has a established history in detector-based spectral CT, a technology that has gained substantial clinical acceptance. This foundation is supported by over 800 global installations and backed by more than 800 peer-reviewed publications. The company's spectral CT technology is already fully embedded into routine clinical workflows through PACS-native delivery.
How Verida's AI Technology Enhances Care
The core advantage of spectral CT is its ability to measure how different tissues absorb various x-ray energy levels. This allows clinicians to differentiate between materials that would appear identical on a conventional CT scan. Philips pioneered the detector-based approach, which delivers multiple spectral results from a single scan without compromising on performance or increasing scan time.
With Verida, this capability is supercharged. The system's AI integration generates industry-leading spectral image quality with minimal noise, in addition to producing high-definition conventional images. The practical benefits for patients and healthcare facilities are substantial. Verida can achieve dramatic dose reduction without compromising diagnostic clarity and reduces energy consumption by up to 45% compared to previous systems.
Clinical Impact and Workflow Efficiency
The system's impact is already generating excitement among medical professionals. Prof. Eliseo Vañó Galván, a cardiovascular radiologist and Chairman of the CT & MR Department at Hospital Nuestra Sra. Del Rosario in Madrid, Spain, commented on the clinical potential. "The clinical benefits of Verida will fundamentally change my approach to cardiac imaging," he stated. "With more comprehensive insights in every cardiac CT, I plan to make spectral imaging routine for all patients."
Professor Vañó Galván's team evaluated multiple systems, including photon-counting CT, but ultimately selected the Philips platform for its precision and user-friendly design. He noted that the technology could potentially reduce the need for invasive angiograms, not only in cardiology but across other clinical areas as well.
From an operational perspective, Verida offers remarkable efficiency gains. The system reconstructs 145 images per second, allowing entire exams to automatically appear in less than 30 seconds. This is twice as fast as previous systems and enables a facility to perform up to 270 exams every day, significantly improving patient throughput.
Building on Philips' proprietary Spectral Precise Image technology—a deep learning AI reconstruction engine combined with advanced spectral imaging—and its third-generation Nano-panel Precise dual-layer detector, Verida is engineered to deliver faster, more dose-efficient spectral reconstructions. This empowers clinicians to access rich spectral information from a single, efficient scan, potentially transforming diagnostic pathways across multiple medical specialties.
